author-photo

Hideyuki Mishima

Aichi Medical University

88

Papers

871

Citations

Citation Trend

Filter By

Papers (88) Sort By

JournalConferenceOthers

Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).

2021 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of celecoxib as preemptive analgesia for patients undergoing laparoscopic inguinal hernia repair: a randomized trial

2021 Surgery Today
Show All
- Source
- Cite
- Save
Citations (1)
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS study).

2020 Oncologist
Show All
- Source
- Cite
- Save
Citations (8)
Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naive older or frail patients with metastatic colorectal cancer (OGSG 0802).

2020 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
P-37 phase II study of oxaliplatin-based regimen in relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: INSPIRE study

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of sex and histology on the therapeutic effects of fluoropyrimidines and oxaliplatin plus bevacizumab for patients with metastatic colorectal cancer in the SOFT trial

2020
Show All
- Source
- Cite
- Save
Citations (1)
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study

2019 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (11)
Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
571PRandomized phase III study of sequential treatment with capecitabine or 5-fluorouracil (FP) plus bevacizumab (BEV) followed by the addition with oxaliplatin (OX) versus initial combination with OX+FP+ BEV in the first-line chemotherapy for metastatic colorectal cancer: The C-cubed study

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

2019 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (8)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号